Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kamran Aryana
Observed names:
Aryana Kamran,
K. Aryana,
Kamran Ariana
Institutions:
Mashhad University of Medical Sciences,
Ghaem Hospital
Observed institutions:
Mashhad University of Medical Sciences,
Emam Reza Hospital,
Imam Reza Hospital,
Ghaem Hospital,
Tehran University of Medical Sciences
ORCID:
0000-0003-2403-8903
Observed ORCID:
0000-0003-2403-8903
OpenAlex ID:
A5062437542
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review
2021
·
Giorgio Treglia
, Barbara Muoio
, et al.
·
International Journal of Molecular Sciences
·
55
PDF
Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer
2011
·
Mohsen Aliakbarian
, Bahram Memar
, et al.
·
The American Journal of Surgery
·
44
Could Fibroblast Activation Protein (FAP)‐Specific Radioligands Be Considered as Pan‐Tumor Agents?
2022
·
Hessamoddin Roustaei
, Zahra Kiamanesh
, et al.
·
Contrast Media & Molecular Imaging
·
33
PDF
Botulinum toxin for prevention of delayed gastric emptying after esophagectomy
2013
·
Reza Bagheri
, Seyed Hossein Fattahi
, et al.
·
Asian Cardiovascular and Thoracic Annals
·
32
99mTc-labeled ubiquicidin scintigraphy: A promising method in hip prosthesis infection diagnosis
2012
·
K. Aryana
, A. Hootkani
, et al.
·
Nuklearmedizin - NuclearMedicine
·
29
Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis.
2013
·
Narjess Ayati
, Kamran Aryana
, et al.
·
PubMed Central
·
23
PDF
Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions
2014
·
Farzaneh Shariati
, Kamran Aryana
, et al.
·
Nuclear Medicine Communications
·
21
Fibroblast Activation Protein Inhibitor Imaging and Therapy in a Patient With Multiple Endocrine Neoplasia Type 2A Syndrome
2022
·
Somaye Barashki
, Ghasemali Divband
, et al.
·
Clinical Nuclear Medicine
·
20
The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA
2018
·
Hojjat Ahmadzadehfar
, Kamran Aryana
, et al.
·
Iranian Journal of Nuclear Medicine
·
18
Association of Helicobacter pylori infection with the Lewis and ABO blood groups in dyspeptic patients
2013
·
MohammadReza Keramati
, SeyedRasoul Zakavi
, et al.
·
Nigerian Medical Journal
·
16
Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA: A Chance for 177Lu-DOTATATE Therapy?
2021
·
Farnaz Nesari Javan
, Kamran Aryana
, et al.
·
Clinical Nuclear Medicine
·
15
68Ga-FAPI-46 PET/CT in a Metastatic Castration-Resistant Prostate Cancer Patient With Low PSMA Expression
2022
·
Kamran Aryana
, Reyhaneh Manafi-Farid
, et al.
·
Clinical Nuclear Medicine
·
14
Systemic Absorption of Tc-99m-Pertechnetate during Dacryoscintigraphy: A Note of Caution
2010
·
Narjess-Khatoon Ayati
, Reza Gholami Malekshahi
, et al.
·
Orbit
·
14
Utilizing 99mTc-FAPI-46 SPECT/CT in Detection of Peritoneal Carcinomatosis in Gastric Poorly Differentiated Adenocarcinoma: A Case Report
2024
·
Nasrin Raeisi
, Amin Saber Tanha
, et al.
·
Clinical Nuclear Medicine
·
12
Diagnostic value of 99mTc-ubiquicidin scintigraphy in differentiation between osteomyelitis and bone tumors
2017
·
Narjess Ayati
, Mohammad Norouzi
, et al.
·
Nuclear Medicine Communications
·
12
Combination Therapy With 177Lu-FAPI-2286 and Tyrosine Kinase Inhibitor: A Novel Approach for Treating Metastatic Medullary Thyroid Carcinoma
2025
·
Nasrin Raeisi
, Amin Saber Tanha
, et al.
·
Clinical Nuclear Medicine
·
11
177Lu-FAPI-2286 Therapy in a Patient With Radio-iodine Refractory Papillary Thyroid Carcinoma: A Favorable Clinical and Biochemical Response
2025
·
Nasrin Raeisi
, Amin Saber Tanha
, et al.
·
Clinical Nuclear Medicine
·
11
Efficacy, safety and prognostic factors affecting overall survival among metastatic prostate cancer patients undergoing treatment with 177Lu-PSMA-617: A single center study
2021
·
Soroush Zarehparvar Moghadam
, Emran Askari
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
·
11
Favorable Response After Only One Cycle of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Metastatic Merkel Cell Carcinoma
2019
·
Soroush Zarehparvar Moghadam
, Ghasemali Divband
, et al.
·
Clinical Nuclear Medicine
·
11
99mTc-PSMA and 99mTc-FAPI-46 Uptake in Pulmonary Lymphangitic Carcinomatosis: A Rare Form of Metastasis in Prostate Cancer Patient, Responding to Modified Treatments
2024
·
Nasrin Raeisi
, Atena Aghaee
, et al.
·
Clinical Nuclear Medicine
·
10
[68 Ga]Ga-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression
2024
·
Hessamoddin Roustaei
, Habibeh Vosoughi
, et al.
·
European Journal of Radiology
·
10
PDF
Application of 99mTc-FAPI-46 Imaging in a Patient With Medullary Thyroid Carcinoma: Navigating the Landscape of Novel Radiotracers
2024
·
Nasrin Raeisi
, Amin Saber Tanha
, et al.
·
Clinical Nuclear Medicine
·
9
Nano Liposomes Labeled with (99m)Tc-HMPAO, a Novel Agent for Blood Pool Imaging.
2015
·
Kayvan Sadri
, Salimeh Momenypoor
, et al.
·
PubMed Central
·
9
PDF
Favorable Palliative Effect of 177Lu-FAPI-2286 in Two Breast Cancer Patients With Refractory Bone Pains
2025
·
Nasrin Raeisi
, Amin Saber Tanha
, et al.
·
Clinical Nuclear Medicine
·
8
A dataset of [68Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma
2023
·
Hessamoddin Roustaei
, Nasim Norouzbeigi
, et al.
·
Data in Brief
·
8
Show more works
View as search
Works count:
120
Citation count:
632
H-index:
13
I10-index:
21
Year
Topic
Type